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ABSTRACT 
 
Aims: This is an innovative cell-based research project focused on the hair follicle dermal papillae 
(DP) as a source of key-element cells for regeneration of hair growth. DP is major dermal 
compartment which has a role in hair formation at embryogenesis and is able to differentiate down 
an endothelial lineage for in vitro functional assays. In the present study, we have tested the 
potential of DP cells from the lower end bulb region of hair follicles for multilineage differentiation              
in vivo. We have postulated that DP cells’ epigenetics can be changed under the influence of 
embryonic microenvironment when they are injected into early embryos which would demonstrate 
plasticity, regenerative and inductive properties of hair follicle dermal cells.  
Original Research Article 
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Study Design: Pilot research. 
Place and Duration of Study: School of Biological and Biomedical Sciences, University of 
Durham, the UK, between February 2007 and December 2009. 
Methodology: To identify the capacity of functional contribution to organogenesis we microinjected 
various numbers of Green Fluorescence Protein (GFP)-expressing Dermal Papillae cells (GFP-DP 
cells) into mice blastocysts and transferred embryos to the foster mothers for the generation of 
chimeric fetuses.  
Results: GFP-expressing cells were detected in 3% of the epiblast egg cylinders formed from 
microinjected blastocysts cultured in absence or presence of mouse embryonic fibroblasts (MEFs). 
Surgical transfer of microinjected blastocysts resulted in 4.5% of fetuses developing fully. GFP- DP 
cell lineages were detected in tissue samples under fluorescence and confirmed 
immunohistochemically. Our finding displayed subcultural localization of GFP as a proof of 
chimaeric tissue from unborn pups carrying DP cell lineages which had multiplied in bone marrow, 
parenchyma and connective tissue, brain and hair bulbs.  
Conclusion: The results confirm the capability of a small population of DP cells to convert into 
embryonic stem-like cells, multiply and contribute to organs and tissue. This makes them a 
reasonable source for regenerative studies and replacement therapy. 
 
 
Keywords: Dermal papillae cells; blastocyst; microinjection; differentiation; pluripotency. 
 
1. INTRODUCTION 
 
The capability of epigenetic reprogramming 
somatic cells to convert into embryonic stem- like 
cells attracts much attention because of the 
potential for customized transplantation therapy, 
as cellular derivatives of reprogrammed cells will 
not be rejected [1-3]. The DNA methylation, gene 
expression and chromatin state of such induced 
reprogrammed cells are similar to ES cells [4-6]. 
Innovative cell-based therapies have focused on 
the dermal papillae cells (DPCs) as a way to 
grow new hair in previously bald areas. Current 
research in this area tended towards the use of 
developmental biology-based tissue engineering 
approaches to try to create a skin equivalent that 
will produce hair follicles when grafted in vivo              
[7,8]. 
 
The dermal papilla is the major dermal 
compartment in hair formation during embryonic 
morphogenesis and hair cycling after birth [9-11]. 
Dermal cells in the lower end bulb region of hair 
follicles are highly active and able to differentiate 
down an endothelial lineage and they exhibit 
similar functional characteristics to endothelial 
cells in in vitro functional assays. Data suggest 
that the majority of DP cells in primary cultures 
have the ability to function as endothelial cells 
when exposed to angiogenic signals in vitro            
[12-14]. The identification of dermal papillae 
cells’ properties is previously clearly documented 
in vivo and in vitro, confirmed in situ and 
detected by transmission electronic microscopy 
[15,16].  
Studies suggest dermal papillae (DP) cells are a 
source of key element-cells for regenerating hair 
growth. Because DPs are located at the base of 
the hair follicle, which is a unique tissue 
surrounded by epithelial matrix cells, they 
provide regulating factors and nutrients to 
support the proliferation and differentiation of the 
epithelial matrix cells in hair cycle progression 
and also in follicle formation in embryonic skin 
[17-19]. Cells from DPs possess several 
characteristics that distinguish them as adipose-
derived MSCs (mesenchymal stromal stem 
cells), including their capacity to self-renew 
indefinitely and differentiate into cells of other 
follicular or interfollicular regions [20].  
 
Previous basic research revealed that dermal 
macroenvironment is important in the 
maintenance of bulb cell population and hair 
follicle growth [21,22]. Based on findings that 
demonstrate the plasticity as well as regenerative 
and inductive properties of hair follicle dermal 
cells [23,24], we have postulated that their 
epigenetic can be changed under the influence 
of an embryonic microenvironment when DPCs 
are injected into the cavity of an expanded 
blastocyst. They may multiply and contribute to 
organs and tissue of mosaic animal models after 
transferring microinjected embryos to foster 
mothers.  
 
In comparison to the newly verified potential of a 
few proteins to undergo direct reprogramming, 
the microinjection technique is a useful tool to 
determine the unique capability of early pre-
implantation embryos to return from a status of 
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multipotent cells back to embryonic by 
“collaboration” with embryonic blastomeres. This 
is because of the earlier embryos’ possession of 
secret transcriptioning factors that are the main 
key of cellular toti- and pluripotency [21]. 
Previous research detected that the cells derived 
from mouse embryonic fibroblasts and injected 
into blastocysts are able to promote the 
epigenetic reprogramming of their genome to an 
embryonic state [4]. Papillae cells derived from 
hair follicles demonstrate a lower proliferative 
capacity compared to dermal fibroblasts but can 
be serially cultured for a long period without 
losing their hair-inductive potency [20,25].  
 
Because of our interest in testing DP cells’ 
pluripotency under blastocyst control, we 
examined the development of microinjected 
embryos in vitro in the absence and presence of 
MEFs. Our results indicated that a part of DP 
cells is able to rapidly differentiate into 
embryonic-like cells contributing to epiblast 
cylinders. Furthermore, we demonstrated that 
mosaic fetal tissue possesses some chimerism 
resulting from DP cells’ microinjection. Because 
microinjected DP cells gave a start to 
multilineage differentiation, the pluripotent 
property of these cells is evidenced under certain 
conditions. Our results revealed that DP cells are 
not only able to produce skin type cells but, 
examined in development in vivo, they showed 
the ability to differentiate into several somatic cell 
types of the embryo proper, suggesting that DP 
cells can be reprogrammed to assume a state 
analogous to the embryonic stem-like cells. We 
have shown that cellular GFP markers from 
GFP-expressing DP cells were found in various 
organs and tissues of the fetuses derived from 
the microinjected blastocysts as a result of fusion 
events between DP cells and original embryonic 
blastomeres. 
 
2. MATERIALS AND METHODS  
 
2.1 Cell Isolation and Maintenance  
 
The most widely used method to isolate DP 
population is surgical microdissection, which has 
been successfully established in rodent vibrissae 
follicles [15,22]. GFP-expressing DPCs were 
obtained from the hair bulbs of mutant transgenic 
mice line C57BL/6 with an “enhanced” GFP 
cDNA under the control of a specific promoter 
(human ibiqutin C) which makes all tissue 
express GFP. We used 18 animals, 24-72 weeks 
old, both males and females as GFP-DPCs 
donors.  
Briefly, the vibrissae were pulled forward and an 
arching incision was made under the eye, from 
mouth up to the bridge of the nose. The incision 
in the vibrissae area was dissected to separate 
the outer and fur layers from the underlying 
surrounding connective tissue. The largest hair 
follicles were selected to separate their proximal-
most tips. After removal they were placed in 
individual drops of DMEM (Dulbecco Modified 
Eagle’ Media) with antibiotics (0.1%) and 
antifungal (0.2%). Specific dissection technique 
was used to minimize contamination of the DP 
cell population with other mesenchymal and 
epithelial cells and matrix [19]. After isolation of 
collagen capsules, the papillae were then 
transferred to a 1 ml well in a four-well plate that 
contained 20% FBS in DMEM. A fine pointed 
needle was used to separate the outer dermal 
sheath layer and part the epidermal matrix 
component from around dermal papillae in each 
end bulb under a microscope x10. Each well 
contained 4-5 papillae to increase the chance 
that they would adhere for a few days. Papillae 
were cultured in a medium known to induce 
adipocyte and osteocyte differentiation [20]. The 
outgrowth of DPCs was observed with flattened 
and polygonal morphology. Cells were 
propagated by changing media until spheres 
formed around the papillae. When an appropriate 
confluence was reached the cells were 
transferred to a larger culture flask into ESC 
media based on DMEM containing non-essential 
amino acid (NEAA), β-mercaptoethanol and 20% 
FCS. They were further cultured for over 1 month 
until a homogenous cell population was created, 
then dispersed by repeated pipetting and seeded 
for use as a single cell suspension at various 
passages (p 3-4 or p 6-8) for blastocyst 
microinjection. 
 
2.2 Embryo Handling and Blastocyst 
Microinjection for in vitro and in vivo 
Studies 
 
Day 3.5 blastocysts were flushed from the uteri 
of pregnant females from inbred mice line 
BALB/c (C57BL/6j x CBA/j) F1 that had mated 
with the same males in natural oestrous                
(in vitro trials) or after hormonal induction of 
superovulation (in vivo studies) to get a bigger 
number of injectable embryos. The uterine horns 
were flushed with M2 medium while the embryos 
were washed briefly in a few M2 medium drops 
and kept in M16 medium droplets at 5% CO2 and 
38°C.  
 
Microinjections were performed with Eppendorf 
Manipulation system in M2 medium, 5-10 or            
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10-15 DP cells into each fully-expanded 
blastocyst. Microinjected embryos were placed 
into KSOM medium drop at 5% CO2 and 38°C to 
revive and re-expand after a collapse caused by 
a micropipette penetration, till all microinjection 
procedures were complete.  
 
2.3 Long-term Embryo Culture and 
Generation of Novel ESC Lines from 
Microinjected Blastocysts 
 
Mouse Embryonic Fibroblasts (MEFs) were 
prepared from 13 to 14 day prenatal fetuses and 
used to get a feeder MEF layer for novel ESC 
line derivation. MEFs were treated for mitotic 
inactivation through exposure in culture to              
1 µg/mL solution of mitomycin C in DMEM, plus 
10% FBS supplemented with 2 mM L-glutamine 
and antibiotic, 1 mM sodium pyruvate, 0.1 mM 
MEM nonessential amino-acids (NEAA), and 0.2 
mM β-mercaptoethanol (Feeder medium), for 2 
hours. After washes (x3 times) in Dulbecco’ 
phosphate buffer solution (DPBS) feeder cells 
were plated at a density of 5 x 104 cells per cm2 
and used at passage 3 (p3).  
 
Blastocysts were microinjected with 5-10 GFP-
DPCs at passage 6-8 (p6-8), cultured for 2 hours 
and observed under a fluorescent microscope to 
ensure GFP-DPCs were incorporated into the 
blastocysts’ cavities. The embryos recognized as 
bearing GFP-positive DP cells were placed into 
groups of 20-25 embryos or seeded individually 
for long-term culture in DMEM media (Gibco) 
supplemented with 2.2 g/L NaHCO3, 2 mM L-
glutamine (Sigma), 0.1 mM β-mercaptoethanol 
(Sigma), 20% heat-inactivated FCS (HyClone). 
4x103 U/mL LIF was added at day 5 and on 
every proceeding second day till substantial 
epiblast outgrowths had formed. Microinjected 
embryos were cultured in groups for 12 days and 
the saved GFP-expressing DP cells and dynamic 
changes in embryonic morphology were 
monitored under a fluorescent microscope. 
  
Individual culture of microinjected embryos 
suggested the application of MEFs. The epiblast 
egg cylinders were detached from the 
trophoblast monolayer outgrowth using a glass 
pipette tip, transferred via a few 20 µL drops of 
trypsin solution (disaggregation), DMEM plus 
20% FCS (trypsin inactivation) and DPBS (for 
rinsing) to separate the epiblast into the small 
cell clumps. These were then incubated for the 
next 48 hours. The newly formed epiblast cell 
clumps were detached in the same way and 
transferred into fresh wells of inactivated MEFs. 
When epiblast outgrowths were formed the cycle 
was repeated. 4-5 days after the last picking and 
seeding the feeder wells containing primary ESC 
colonies were observed under a fluorescent 
microscope to assess GFP expression of 
multiplied GFP-DPCs.  
 
2.4 Embryo Transfer 
 
Microinjected blastocysts were surgically 
transferred into uteri of pseudo-pregnant CD-1 
Albino females, 12-15 embryos unilaterally or 16-
20 bilaterally per mouse. The pregnant females 
were sacrificed when they reached E16.5, E18.5 
and E20.5. Foetuses were removed by 
caesarean section to evaluate the chimerism 
level and GFP expression of DP cell lineage.  
 
2.5 Immunofluorescent Analysis of GFP 
Expression 
 
Rinsed from blood, the fetuses were fixed in 4% 
paraformaldehyde solution in PBS at 4°C for 1 
hour and 20% sucrose in PBS at room 
temperature (RT) overnight, dissected to three 
parts, then placed in embedding chambers with 
O.C.T. 4583 (Tissue-Tek, Sakura) and slowly 
frozen. Parts of the fetuses were sectioned 
vertically using Leica CM3050S cryostat to a 
thickness of 8µm. Serial 8 µm sections were 
taken as tissue sample pairs with 24 µm intervals 
between every third pair, placed on microscope 
adhesive slides and stored in air-light moisture 
protected chambers at -80°C. Each pair of slides 
were screened either under a fluorescent 
microscope or stained with GFP-antibodies to 
catch GFP- DP cell lineages in respect to all 
organ and skin structures. Frozen sections were 
washed in 0.2% Tween-20 in PBS (x 3), 
acetylated and dehydrated through graded 
ethanol series with using Haematoxylin-eosin 
staining. Sections were cover slipped with DPX 
mounting media (Maviol) and 2% DAPI in PBS 
and visualized in real time to recognise GFP 
expression.  
 
Fluorescent microscopy was applied to identify 
GFP using a Carl Zeiss Imager M1, AXIO HBO 
100 and a laser excitation wavelength of 488 nm. 
GFP fluorescence was recorded using band pass 
505-550 nm filters and 56-57.8 um pinhole 
diameters. Red spectrum wavelengths were 
excited with 543 nm laser and recorded using 
long pass 560 nm filters and 62.0-63.0 um 
pinhole diameters. GFP expression was detected 
using enhanced chemiluminescence and 
captured by the FluorChem 8900 Imaging 
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system (Alpha Innotech). GFP-positive and GFP-
negative control tissue samples had been 
prepared previously and were used to compare 
GFP expression intensity.  
 
2.6 Immunohistochemical Analysis / 
Staining with GFP Antibody 
 
The slides were washed in 0.3% Triton x 100 in 
PBS to increase the cell membranes’ 
permeability, then rinsed in PBS (2 x 5 min) 
using a shaker. The rest of the liquid was 
removed, and a block goat serum diluted 1:10 
was used (30 min incubation at RT in wet 
chamber). Primary GFP rabbit polyclonal 
antibody ab290 (Abcam) was added in dilution 
1:2000 in PBS, and slides were incubated for 1 
hour at 37°C under a paraffin film. After washing 
in PBS (3x5 min) excess liquid was removed and 
a secondary goat antibody 66s was added in 
dilution 1:500 with following incubation period for 
1 hour at RT in air-light preserved and wet 
chambers. The slides were carefully and 
thoroughly washed in PBS (3x5 min) with a 
shaker. The incubation with 3% hydrogen 
peroxide (Sigma) for 7 min at RT was aimed to 
inactivate cells and tissues that have auto 
fluorescence. Solution Strept AB Complex 
(Streptavidin HRP Conjugate, HRP Duet 
Mouse/Rabbit, DK-2600, DAKO) in dilution 1:250 
in PBS was used to fix the secondary antibody, 
with an incubation time of 30 min at RT and a 
short 5 min rinse after that. To finish the glass 
slides were incubated for 5 min with toxic 
solution (Diaminobenzidine, D4293-50, Sigma, 
dissolved in distilled water). Finally the slides 
were rinsed in distilled water, acetylated and 
dehydrated through graded ethanol series using 
Haematoxylin solution (Fluka). After 5 min 
washing in Histoclear solution the sections were 
cover slipped with DPX mounting media (Maviol, 
R 1340, Agar Scientific).  
 
3. RESULTS  
 
3.1 Establishment of Dermal Papillae Cell 
Culture 
 
As previously noted, DP cells were isolated from 
C57BL/6 mice with an “enhanced” GFP cDNA. 
This mice strain demonstrates a high proportion 
of GFP-expressing cell populations in epidermis, 
bone marrow, thymus, spleen, uterus and 
peripheral blood. The hair follicle bulbs are more 
easily distinguished in the fat and connection 
tissues of the vibrissae area because of black 
phenotype. More prospective follicles located in 
the dorsal area, and young animals are 
preferable donors for primary DPC culture [16]. 
Vibrissae end follicle bulbs were dissected from 
the mistrial pad of GFP-transgenic adult mice, 
and primary cell cultures were established from 
the papillae explants. Primary follicle dermal 
explants formed spheres in culture on laminin 
coating substrate, as described [18]. The 
cultured papillae cells spread slowly, initially as a 
monolayer, and eventually formed multi-layered 
arrays of fibroblast-like cells. At the edges of the 
expansion, the cell colonies were larger and 
flattened and showed a tendency to form clumps. 
Produced DP cell lines displayed the extended 
proliferative capabilities and at 3-4 passages 
were ready for microinjection. Most of the 
visualized DP cells, about 70-80%, were 
recognized as GFP-positive expressing 
(fluorescent microscopy applied), typical size           
5-15 µm. Employing a laser excitation 
wavelength of 488 nm showed high fluorescence 
in round DP cells. We suggest dead or elongated 
cells that didn’t restore their round shape after 
trypsin treatment (for disruption of cell 
monolayer) don’t diffuse fluorescence. The round 
DP cells are actively dividing cells that rounded 
up in the process of dividing and they were 
chosen for cell microinjection.  
 
3.2 Assessment Ability of Microinjected 
Blastocysts to Survive in vitro  
 
To identify ability of hair follicle cells to function in 
a similar manner to embryonic stem cells during 
development, we injected GFP expressing DPCs 
into D3.5 blastocysts harvested from mice that 
did not carry the GFP gene. Blastocysts (n=164) 
deposited into a drop of the M2 medium 
containing a suspension of GFP-DP cells were 
injected with 5-10 DP cells per embryo through 
the trophoblastic layer into blastocoels (Fig. 1).  
 
GFP protein expression was used as a specific 
reporter for visualizing successful cell 
microinjection. In a few cases, due to a high 
pressure in the cavities of some over expanded 
blastocysts, DPCs were recognized as having 
gone out into perivitelline space. This led to the 
loss of injected cells at blastocyst hatching. 
Microinjected embryos were analyzed for the 
presence of GFP-DP cells under fluorescent 
microscopy with a FITC filter set (BP 450-512 
nm, DM 512 nm, BF 515 nm). 12 hours later 
GFP-DP cells were detected in 43.3% 
blastocysts (71 out 164 injected), in 41.5% at 24 
hours, in 36.6% at 48 hours, and in 35.4% (36 
out of 104) at 72 hours. GFP protein expression 
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rate remained stable for the next 24 hours            
(Fig. 2). Blastocysts attached to the bottom of a 
Petri dish and developed spontaneously. A 
culture media was changed just once on the 4th 
day in order to avoid some morphological 
damages. The 5th day was noted as a final day 
for the formation of epiblast outgrowths from 
hatched embryos. 
 
 
 
Fig. 1. Microinjection of GFP-expressing Dermal 
papillae cells (DPCs) into mice blastocysts. 
Panel shows a photomicrograph of DPCs 
cultured before microinjection (A). Microinjection 
of GFP-DPCs into a blastocyst step-by-step (B, 
C, D). Panel E shows DP cell culture consisting 
from GFP-positive and GFP-negative cells (dead 
or elongated cells that didn’t restore round shape 
after detachment from laminin coating            
surface). Fluorescent photomicrographs show 
corresponding GFP-expressing cells in re-
expanded and half-hatched blastocysts the day 
after microinjection (F, G, H). Panels I and J 
demonstrate injected blastocysts with DPCs 
corresponding to GFP expression as single and 
multiple green signals. Some injected cells 
dissociated and distributed between embryo 
primary blastomeres. They are not visible in 
transmitted light (K) but easy distinguishable by 
fluorescence (L). 
 
At 120 hours the rate of GFP expression in 
cultured blastocysts decreased to 23.8%. Some 
epiblastic clumps spontaneously detached from 
the trophoblastic layer and swam in the upper 
layer of culture media as hardly-visible flakes. On 
days 6 and 7 GFP-expressing cells were 
recognized in 17.1% and 16.5% cell epiblasts, 
accordingly. They continued to express a low 
intensity fluorescent signal on days 8 and 9, 
localized in 13.4% and 9.7% cell epiblasts. 
During culture GFP-DP cells did not show a 
greater number than when initially injected but at 
day 12 a weak fluorescence was still visible, 
detected in 5 cell spheres (Table 1).  
 
 
 
Fig. 2. Fluorescent light images of hatched 
blastocysts microinjected with 5-10 injected 
DPCs which carry a green fluorescent protein 
(GFP) marker and cultured during 12 days 
without feeder cells. Photomicrographs show 
microinjected blastocysts cultured in vitro for 48 
hours (A, B) and 96 hours (C), on day 5 (D) and 
day 6 (E, F) after passing. Panels G and H show 
residual GFP markers that were still visible in 
very small cellular compartment on days 9 and 
12 after passing.  
 
To extend our in vitro trials we checked the 
hypothesis that DP cells would better incorporate 
into blastocysts if the microinjected embryos 
were seeded and cultured on the inactivated 
MEFs. The study aimed to derive novel ES cell 
lines and to this end we microinjected 85 
blastocysts with 5-10 GFP-DP cells. They were 
evaluated as the embryos with well-identified 
GFP protein expression. During culturing the 
hatched blastocysts formed epiblast outgrowths 
suitable for picking up within the next 2 days and 
which reflected visibly bright GFP signal.
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Table 1. Summary of in vitro and in vivo survival of GFP-dermal papillae cells microinjected 
into blastocysts 
 
Methods Embryos 
handling 
condition 
No. 
microinjected 
blastocysts  
GFP-DP 
cells 
number and 
passage  
Value of GFP cDNA 
expression in embryos / 
foetuses after cell 
microinjection at 
Start 
point 
The end of 
culturing 
In vitro  
Long term culture for 12 
days. In absence of 
feeder  MEFs 
Flushed 
from 
females in 
natural 
oestrus 
 
164  
 
 
 
5-10 cells  
p6-8 
 
 
43.3% 
 
 
3% 
 
 
 
In vitro  
Targeted to novel ESCs 
lineages generation. In 
presence of MEFs  
85  
 
 
5-10 cells  
p6-8 
 
 
47% 
 
 
 
Wasn’t detected 
 
 
In vivo development. 
Experimental group 
Flushed 
form 
females in 
induced 
oestrus 
598 
microinjected 
534 transferred 
to 28 foster 
mothers 
10-15 cells  
p3-4 
 
 
89.3% 
 
 
 
 
Pregnancy rate - 
35.7% 
Embryo recovery 
rate 4.5%  
In vivo development. 
Control group 
Intact 50  
Transferred to 3 
foster mothers 
No cells/ 
No micro 
injection 
 
 Pregnancy rate 
100% ,  
Embryo recovery 
rate 30% 
Abbreviations: GFP, Green fluorescence protein; MEFs, Mouse embryonic fibroblasts; DPCs, Dermal papillae cells 
 
We detected GFP-DP cells contributed to 47% of 
the epiblast cylinders (40 out 85). The rest of the 
blastocysts examined failed to hatch or had no 
visible GFP-expression. After first picking and 
cell disaggregation, 22.2% of the epiblast tips 
showed weak visible fluorescence, nearly ¼ of 
the initial rate, but after second picking only 
individual epiblast tips were observed as GFP-
expressing (Fig. 3). 
 
3.3 Assessment of in vivo Chimerism              
in Foetuses and Survival of DP Cells 
in Uterine Environment  
 
DP cells were tested for the ability to contribute 
to embryonic architecture and generate chimeras 
by the microinjection of GFP-DP cells into 
blastocysts (n=555) and into compacted morulae 
that reached blastocyst stage in KSOM media for 
2 hours (n=43). In total, 598 blastocysts were 
successfully injected with 10-15 GFP-DPCs (p3-
4) and then 534 embryos (89.3%) were 
transferred to the 28 CD-1 foster mothers after 
fluorescent estimation confirming DP cells’ 
incorporation. To compare the main indexes 
such as a pregnancy level and embryo recovery 
rate 50 intact blastocysts were transferred to the 
3 foster females. 
The recipient females were sacrificed at the 13th, 
15th and 17th days that corellate with day of 
embryo development E16.5, E18.5 and E20.5. 
Pregnancy was detected in 35.7% females (10 
out 28) in the experimental group. In total 24 
sites (4.5% embryo recovery rate, 24 out 534) 
were found at caesarean sectioning and 18 out 
24 were considered as full-time developed 
fetuses. Care was taken to calculate the number 
of non pregnant recipients, encapsulated 
embryos, partially resorbed fetuses (placenta 
rests) and females with arrested development. 
All 3 females in the control group became 
pregnant (30% embryo recovery rate, 15 out 50) 
versus 4.5% in experimental group (P= .01).  
 
Fluorescent microscopy was employed to detect 
tissue-located GFP-expressive cell lineages. Two 
full-time developed foetuses were suspected of 
significant incorporation of GFP+cells that were 
visible at resolution x10 (Fig. 4). Both foetuses 
showed detectable GFP signal in the heads and 
the bodies when cryosectioned and examined 
under an immunofluorescent microscope and this 
was then confirmed with Haematoxylin and Eosin 
staining.  
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Fig. 3. Phase-contrast photomicrographs show 
progressive in vitro embryo development 
following blastocysts hatching and plating (A, B) 
and primary egg epiblast cylinders forming at day 
5-6 after microinjection (C). Panel D shows a 
decreasing cell mass in epiblast tips after picking 
and passing for next 48 hours. Phase-contrast 
microscopy displays a primary cell nest formed 
following cell dissociation of epiblast tips and 
passing them on to a feeder MEFs layer 3 days 
later (E, F). Photomicrographs demonstrate cell 
nests of different morphology raised after the 
second (G and H) and third (I and J) circles of 
cell dissociation. 
 
Our finding suggested that GFP+ cell derivates 
were likely to be present in epiblast-derived 
lineages and this was confirmed 
immunohystochemically by GFP antibody 
staining. GFP-expressing DP cell lineages were 
detected in various proliferating cell types of few 
prenatal foetuses as a proof of DPCs 
multilineage and the capability to contribute to 
chimera formation (Fig.  5).  
 
It is well-known that some organs and tissue 
possess an auto fluorescence that often leads to 
mistakes when software register a nonspecific or 
false-positive signal in metabolically active 
tissue, such as a liver or blood vessels. In order 
to distinguish GFP-false-positive signals from 
microscopic artifacts, we analyzed the selected 
tissue patterns with GFP antibody 
immunostaining. Hydrogen peroxide 3% was 
applied to inactivate the cells and tissue that 
have their own fluorescence. 
 
 
Fig. 4. Full-growth foetuses and those of 
arrested development resulted in surgical 
transfer of blastocysts microinjected with GFP-
expressing DPCs. Panels A and B show 
apparently two fully-developed pups E20.5 
obtained with caesarean section from a foster 
mother. Certain parts of head and body (spine 
area) of fetuses that, according to our 
assumption, had cell lineages derived from GFP-
DP cells (C, D). It was confirmed with low 
resolution microscopy (F: GFP image with             
488 nm illumination; G: Red= RFP image with 
568 nm illumination; H: Green/Red= Alexa 
Fluor@ 647). GFP-expressing cell marker 
demonstrated at merged image (H). 
Abnormalities and defects of embryo 
development due to DPCs microinjection into 
blastocysts: dead foetuses, arrested 
development, partially resorbed and extremely 
small conseptuses as well as multiple sites of 
encapsulated embryos demonstrated in plates I, 
J, K, L. Abbreviations: E20.5, prenatal fetuses 
day 20.5 after mating. 
 
Given the success getting the fetuses after 
transfer of GFP-DPCs microinjected embryos, 
we examined tissue patterns immunohisto-
chemically since the GFP-DP cell lineages are 
represented only in small proportion. Because 
each glass slide had a counterpart, we had the 
opportunity to confirm our findings for the 
patterns that had been previously identified with 
immunfluorescence as bearing a bright GFP 
signal. Immunohistochemical analysis confirmed 
mosaic distribution of GFP-DPCs in all organs 
and tissue of a few fetuses. 
 
The presence of DP cell lineages was 
recognized in ectoderm (the brain, spinal cord, 
and epidermis), endoderm (the liver, lung, heart 
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muscle and other soft organs of abdominal 
cavity) and mesoderm (connective tissue, 
cartilage and bone marrow). GFP expressing DP 
cell derivates were found in skin layers and hair 
bulbs (Fig. 6). 
 
4. DISCUSSION 
 
Earlier experiments in the field of cell 
reprogramming demonstrate that changes of the 
differentiation level in specialized epidermal cells 
can be achieved by nuclear transfer or under the 
influence of four specific genes regulating cell 
pluripotency [2,4,18]. There is evidence that 
induced pluripotent dermal fibroblast can be 
involved in the formation of teratomas in timus-
free mouse [23] and defrosted GFP-MEFs 
derived iPSCs can participate in organ structures 
and the tissue building of chimera mouse [24]. 
Other research demonstrates substantial 
differences between adult stem-like cells and 
ESCs after the separation of mixed cell culture 
into GFP+/GFP- cell populations by flow 
cytometry and/or using mixed embryonic bodies 
to transfer under kidney capsules to create 
teratomes [22]. 
 
In this study we made the effort to get evidence 
that the follicular dermal cells, which are within 
cell populations from hair bulbs, possess the 
requisite developmental plasticity to permit 
pluripotential features. Three separate but 
related areas of investigation were discovered in 
current studies: 1- reprogramming or 
transdifferentiation of DPCs to ES-like cells as a 
consequence of microinjecting them into 
blastocysts; 2- capability of DP cells to 
participate in generation of epiblast egg cylinders 
in vitro; 3- ability microinjected DP cells to 
survive in a uterus. 
 
Mouse embryos handled from the females as of 
natural oestrus and those of induced hormonal 
superovulation were used to microinject with 
GFP-DPCs. We didn’t note any embryonic 
morphological variation nor any difference of 
embryo viability or injectability. Assessment 
showed that approximately 50% of blastocysts 
did not re-expand after the collapse caused with 
cell microinjection and no blastocoels could be 
seen. Some of them did not relieve zona 
pellucida completely even if trophoblastic cells 
spread as a layer on the plastic surface in the 
presence or absence of MEFs. The DP cells 
penetrating through a zona pellucida allowed 
blastocysts to hatch but we observed in vitro 
cases of non reversed blastocyst collapse: 
56.7% blastocysts in absence of MEFs and 53% 
blastocysts cultured on MEFs. Our suggestion 
that some developmental failures could have 
arisen due to DPCs microinjection found 
evidence in the studies in vivo.  
 
 
 
Fig. 5. Fluorescence microscopy in stained,                
8-µm sections of OCT Tissue Tek-embedded 
foetal tissue derived from microinjected embryos. 
The antigenicity of the GFP retained in control 
tissue samples (A-C) of GFP transgenic mice, so 
that GFP localization became visualized after 
immunostaining with anti-GFP antibodies. Panels 
D-U show the fixed and embedded experimental 
patterns. GFP protein expressing cell lineages 
were found in bone marrow and connective 
tissue of body organs (D-F); muscle (G-I); 
cartilage and connective tissue (J-L); visceral 
organs (M-O); in head, bone and brain (P-R), 
and derma (S-U). GREEN = GFP Cells. RED = 
Autofluorescence. GREEN/RED overlap = 
Autofluorescence. 
 
To reveal DPCs capability to convert into 
embryonic-like cells as a result of cell 
microinjection and detect incorporation of clonal 
DPCs into blastocysts, we chose to follow in vivo 
experiment conditions. Fluorescent microscopy 
was used as a specific tool for sorting just those 
DPCs for microinjection as well as culturing and 
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transferring only those injected blastocysts which 
saved bright GFP protein expression [26].  
 
 
 
Fig. 6. Hematoxiline/Eosine staining with GFP-
antibodies of 8 µm cryosections from OCT 
embedded fetuses aimed to locate GFP-
expressing cells as a proof of chimeric tissue 
derived from pups carrying DPC lineages. GFP-
positive cells were found as DPC lineages in 
tissues of prenatal pups: GFP antibody labeled 
these as brown cells in bone marrow, cartilage 
and connective tissues of a hip bone, single cells 
in derma (A); thorax bone (B); central cord (C); 
cartilage tissue around the bone (D), few layers 
of derma and hair follicles (E, F); head bone and 
brain tissue (G-I); visceral organs (J), liver (K), 
trophoblastic and labirinthial layers of             
placenta (L). 
 
The numerous cases of foetus resorbtion, 
necrosis and embryonic death were determined, 
reflecting irreversible events leading to the 
development arrest. Nevertheless, some part of 
DP cell population was activated to proliferate 
but lead to the loss of their slow-cycling. Some 
DP cells integrated into blastocysts’ architecture: 
4.5% embryos implanted and 76% foetuses           
(18 out 24) reached full-time development. 
Results indicate that GPF-expressing DPCs 
multiplied and the lineages contributed to 
derivates from all three germ layers.  
 
In comparison to direct reprogramming, the 
general problem of the microinjection technique 
is a gradual loss of acquired features during 
further prenatal development and keeping just a 
very small cell population in tissues and organs 
of the chimaeric offspring. Embryo recovery rate 
between control (non-microinjected embryos) 
and experimental group (microinjected embryos) 
dramatically decreased; 30% vs 4.5%. The 
argument exists that the embryonic blastomeres 
are more viable and can have a suppression 
effect on injected cells, reducing the contribution 
of that cells to the epiblast. Microinjected cells 
also restrain embryonic blastomeres’ division and 
differentiation. Animals belonging to the 
heterozygous strain could give more prospective 
opportunity as a source of DP cell subpopulation. 
 
To minimize the possibility of essential changes 
in gene expression in GFP-DPCs passed 
through long term culture and subculture (p6-8) 
but providing a large pool of DPCs, we used 
earlier passages (p3-4) for in vivo trials. We 
mentioned that DPCs from earlier passage 
provide better results of embryo survival and that 
microinjection of bigger cell number is more 
trustworthy because more visible GFP 
expression is granted. Due to those simple 
approaches the main aim of the studies was 
reached. Microinjected blastocysts were 
implanted, accomplished gastrulation and 
organogenesis, and gave the birth to full-time 
developed offspring. 
 
These results could be used in support of other 
challenges investigating the role of immune 
effector mechanisms in the death of chimaeric 
embryos and the survival of certain types of adult 
cells in the uterine environment.  
 
5. CONCLUSIONS 
 
We identified hair follicle dermal cells derived 
from adult mice as a cell type with limited 
possibility to pluripotency. The cells of follicular 
dermis from the lower end bulb region of hair 
follicles, namely dermal papillae cells, can 
integrate in blastocysts’ architecture and 
participate in formation both as embryonic egg 
epiblasts and all three germ layers of full-time 
developed fetuses. Our results provide 
compelling evidence that clonal DP lines from 
mouse hair follicle bulbs have extended 
proliferative capability and can change epigenetic 
state under the influence of specific embryonic 
factors and events. They can participate in 
primary cell differentiation contributing to 
chimaeric fetuses and give start to the different 
cell types in various organs and tissues. We also 
assume that the number of specialized DP cells 
possessing the features of stem-like cells with 
high plasticity is boarded but they are able to 
differentiate into lineages associated not only 
with the tissues from which they are derived. 
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The reason for low embryo recovery rate 
reflecting a low level of implanted blastocysts 
could be found in the various degrees of cell 
differentiation, speed of division and epigenetic 
state for cell types, such as clonal DP cells and 
embryonic blastomeres.  
 
In this context, the conclusion that our finding is a 
logical complement to other works in Stem Cell 
Biology can be made: Injection of Dermal 
papillae cells into blastocysts and their 
correspondence with primary embryonic 
blastomeres can initiate changes in their 
biological potency and epigenetic state from 
multipotent to induced pluripotent that are 
indistinguishable from those of ES cells.  
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